Milestone Scientific Inc. (NYSE:MLSS – Get Free Report) major shareholder S.R.L. Bp4 sold 26,855 shares of the company’s stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $0.91, for a total transaction of $24,438.05. Following the completion of the transaction, the insider now owns 9,591,602 shares in the company, valued at approximately $8,728,357.82. This trade represents a 0.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
S.R.L. Bp4 also recently made the following trade(s):
- On Friday, June 6th, S.R.L. Bp4 sold 60,200 shares of Milestone Scientific stock. The stock was sold at an average price of $0.90, for a total transaction of $54,180.00.
- On Thursday, May 29th, S.R.L. Bp4 sold 3,361 shares of Milestone Scientific stock. The stock was sold at an average price of $0.96, for a total transaction of $3,226.56.
- On Wednesday, May 28th, S.R.L. Bp4 sold 14,256 shares of Milestone Scientific stock. The stock was sold at an average price of $0.96, for a total transaction of $13,685.76.
Milestone Scientific Stock Down 2.7%
Shares of NYSE:MLSS opened at $0.89 on Thursday. The company’s 50 day moving average price is $0.94 and its two-hundred day moving average price is $1.00. Milestone Scientific Inc. has a 12-month low of $0.58 and a 12-month high of $1.39. The firm has a market cap of $69.86 million, a PE ratio of -12.72 and a beta of 0.90.
Institutional Inflows and Outflows
Analyst Ratings Changes
Separately, Wall Street Zen began coverage on shares of Milestone Scientific in a research report on Sunday, May 18th. They set a “hold” rating on the stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- Find and Profitably Trade Stocks at 52-Week Lows
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- What is a Stock Market Index and How Do You Use Them?
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.